Author

Aleksandra Olczyk

Mimetas (Netherlands)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1

Frequent Co-Authors

Karla C. S. QueiroziD· 2 shared Thomas OlivieriD· 2 shared Abbie RobinsoniD· 1 shared Arthur Stok· 1 shared Chee Ping NgiD· 1 shared Claudia Al-MardiniiD· 1 shared Dorota KurekiD· 1 shared Gilles S. van TiendereniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Karla C. S. QueirozORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A scalable tumor-vasculature-on-chip for CAR T cell trafficking and efficacy studies

Luuk de Haan, Aleksandra Olczyk, Thomas Olivier, Joris Wesselius, Johnny Suijker, Claudia Al-Mardini, T. Burton, Lenie van den Broek, Karla C. S. Queiroz

This paper describes a scalable tumor-vasculature-on-chip platform to study CAR T cell trafficking and efficacy in a 3D tumor microenvironment.

bioRxiv · Feb 9, 2026 · PreprintBioengineering

Modeling Hepatocellular Carcinoma and its microenvironment on a chip

Orsola Mocellin, Stéphane Treillard, Abbie Robinson, Aleksandra Olczyk, Thomas Olivier, Chee Ping Ng, Arthur Stok, Gilles S. van Tienderen, Monique M. A. Verstegen, Jeroen Heijmans, Dorota Kurek, Sebastian J. Trietsch, Henriëtte L. Lanz, Paul Vulto, Jos Joore, Karla C. S. Queiroz

This study evaluates drug responses in a patient-derived HCC chip model, showing varying effects on tumor cells and microenvironment factors like vasculature and cytokines.

bioRxiv · Jul 10, 2025 · PreprintBioengineering